Cubist Systematic Strategies’s Mirum Pharmaceuticals MIRM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.38M | Sell |
144,950
-151,937
| -51% | -$7.73M | 0.03% | 364 |
|
|
2025
Q1 | $13.4M | Buy |
296,887
+212,918
| +254% | +$9.59M | 0.08% | 154 |
|
|
2024
Q4 | $3.47M | Sell |
83,969
-14,797
| -15% | -$612K | 0.02% | 450 |
|
|
2024
Q3 | $3.85M | Buy |
+98,766
| New | +$3.85M | 0.02% | 442 |
|
|
2024
Q2 | – | Sell |
-7,199
| Closed | -$181K | – | 2167 |
|
|
2024
Q1 | $181K | Sell |
7,199
-47,150
| -87% | -$1.18M | ﹤0.01% | 1698 |
|
|
2023
Q4 | $1.6M | Sell |
54,349
-43,765
| -45% | -$1.29M | 0.01% | 915 |
|
|
2023
Q3 | $3.1M | Buy |
98,114
+94,104
| +2,347% | +$2.97M | 0.02% | 610 |
|
|
2023
Q2 | $104K | Buy |
4,010
+1,976
| +97% | +$51.1K | ﹤0.01% | 1809 |
|
|
2023
Q1 | $48.9K | Buy |
+2,034
| New | +$48.9K | ﹤0.01% | 2525 |
|
|
2022
Q3 | – | Sell |
-42,349
| Closed | -$824K | – | 3782 |
|
|
2022
Q2 | $824K | Buy |
42,349
+26,566
| +168% | +$517K | 0.01% | 2246 |
|
|
2022
Q1 | $348K | Buy |
15,783
+13,134
| +496% | +$290K | ﹤0.01% | 2732 |
|
|
2021
Q4 | $42K | Sell |
2,649
-2,591
| -49% | -$41.1K | ﹤0.01% | 3327 |
|
|
2021
Q3 | $104K | Buy |
5,240
+3,622
| +224% | +$71.9K | ﹤0.01% | 2735 |
|
|
2021
Q2 | $28K | Sell |
1,618
-6,641
| -80% | -$115K | ﹤0.01% | 2833 |
|
|
2021
Q1 | $164K | Sell |
8,259
-1,434
| -15% | -$28.5K | ﹤0.01% | 2533 |
|
|
2020
Q4 | $169K | Buy |
+9,693
| New | +$169K | ﹤0.01% | 2302 |
|
|
2020
Q3 | – | Sell |
-100
| Closed | -$2K | – | 2571 |
|
|
2020
Q2 | $2K | Buy |
+100
| New | +$2K | ﹤0.01% | 2358 |
|